Cannathemag
  • News
  • Magazine
  • Advertising
  • About Us
  • Language Services
  • Contacts
  • Search
  • CZCZ
Facebook Instagram

The EU’s Highest Court Has Ruled: CBD Is Not a Narcotic!

25. November 2020 | Category: News
Towers of the Court of Justice of the EU. Source: Wikimedia Commons

Towers of the Court of Justice of the EU. Source: Wikimedia Commons

On November 19, a major decision came down from the European Union’s highest court which ruled that cannabidiol (CBD) is not a narcotic drug.

The legal squabble from which the decision of the Court of Justice of the European Union arose concerned a dispute between France and a Czech company that sold CBD extracted from the whole cannabis plant for use in electronic cigarette cartridges. It means the CBD product was not extracted just from seeds and fibers (the use of which is provided for in international conventions) but primarily from flowers and leaves.

The argument that “it is a cannabis extract” and thus a narcotic drug, runs counter to the general spirit of the UN conventions.

The Court has recognized this as an unnecessary restriction on the free movement of goods. The ban on the sale of CBD products, based on the argument that “it is a cannabis extract” and thus a narcotic drug, runs counter to the general spirit of the Single Convention on Narcotic Drugs and the Convention on Psychotropic Substances negotiated within the UN many decades ago, since the conventions were aimed at protecting human health.

No harmful effects

CBD, unlike psychoactive THC, “does not appear to have any psychotropic effect or any harmful effect on human health,” the Court said. It further concluded that France was not obliged to prove whether the CBD was as dangerous as a real drug, but to focus on scientific data to ensure that what was a “real risk to public health” would not be “based on purely hypothetical considerations”.

Various CBD and hemp products from family-run cannabis company in the Czech Republic.
Various CBD and hemp products from family-run cannabis company in the Czech Republic.

Such a restriction is also unjustified, as the Court noted, because France has not banned synthetic CBD, which has identical properties to CBD extracts produced from the entire plant.

Crucial moment

The case is far from won, as the European Commission’s preliminary statement that “CBD is a narcotic drug” applies regardless of the ruling of the Court of Justice of the EU. In other words, it is not appropriate to expect that the registrations of novel foods containing plant-derived CBD will start again tomorrow. However, this is a crucial moment, because it is the first time since the European Commission’s preliminary opinion has been issued that such a major EU institution – and a judicial one, at that – has challenged the Commission’s position.

Such a restriction is also unjustified, as the Court noted, because France has not banned synthetic CBD.

And perhaps even more important is the fact that the Court has challenged the flexibility of the interpretation of the Single Convention on Narcotic Drugs in relation to the ban on isolating cannabis resin.

This ruling comes just days after the European Parliament voted in favor of increasing the authorized THC level for industrial hemp from 0.2% to 0.3%.

By Bob Hýsek

Cannabis Therapy – online magazine for cannabis patients and experts alike. Issue No.2 coming soon! In the meantime, check out the issue no. 1 HERE.

Ohodnoťte tento článek
activismanti-inflammatory CBDcannabidiolCannabiscannabis trialEUEuropean CommissionEuropean CourtkannavapeLuxembourgmedical cannabisnarcotic

You might like

  • Source: Unsplash.com News

    Argentina allows patients to grow their own cannabis

  • Source: pixabay.com News

    Large Pharmaceutical Group Takes over Reins of Cannabis Medicine

  • Source: Pexels.com News

    Cannabis job growth exceeds any other industry in the U.S.

Write comment Cancel

Search

Latest News

  • Hana Gabrielová is inviting you to upcoming conference Hemp & Industry in Prague

    24. September 2023
  • Source: Hagit Yagoda

    Activism: Fighting Cancer and Prejudices

    19. September 2023
  • Don’t miss the unique Hemp & Industry conference!

    13. September 2023
  • hemp field in Poland

    Argentinian Hemp Delegation Visits Poland and Czechia

    8. August 2023
Facebook YouTube SoundCloud
  • Advertising
  • Magazine
  • About Us
  • Contacts
  • Terms and Conditions

CANNABIS THERAPY

Magazine about medical uses of cannabis. For patients, health professionals as well as general public. Free of charge.

Contact: office@konomag.cz

Tel.: +420 737 300 375

CATEGORIES

  • Advice
  • Breaking News
  • Health
  • Inspiration
  • Interviews
  • Leaves of Grass
  • News
  • Pharmacopeia
  • Pharmacopoeia
  • Press Release
  • Research Reports
  • Uncategorized
  • Veterinary Medicine

LATEST NEWS

  • Hana Gabrielová is inviting you to upcoming conference Hemp & Industry in Prague

    24. September 2023
  • Source: Hagit Yagoda

    Activism: Fighting Cancer and Prejudices

    19. September 2023

SEARCH

Follow us

Facebook Instagram
  • © 2018-23 CANNABIS THERAPY magazine. All rights belong to their respective owners. Without their written consent it is prohibited to use parts or whole works in any way, particularly spreading and copying, mechanically or electronically, in English, Czech or any other language.

  • Cannathemag

    Manage consent to cookies
    We use technologies such as cookies to store and/or access device information. We do this to improve your browsing experience and display personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or a unique ID on this website. Disagreeing or withdrawing consent may adversely affect certain features and functions.
    Functional Always active
    Technical storage or access is absolutely necessary for the legitimate purpose of enabling the use of a specific service that the subscriber or user has expressly requested, or for the sole purpose of carrying out the transmission of a message via an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    Technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    Technical storage or access is necessary to create user profiles in order to send advertising or track the user across a website or several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    Show preferences
    {title} {title} {title}
    Are you 18+?

    This website requires you to be of legal age. By clicking Yes, you verify you are at least 18 years old.